• About us
• Contact

Advertisement

Document › Details

Verona Pharma plc. (4/27/17). "Press Release: Verona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market [Not for any jurisdiction where distribution would constitute a violation of relevant laws]". London.

	Region	United States (USA)
	Organisation	Verona Pharma plc (AIM: VRP + Nasdaq Global Market : VRNA)
	Group	Verona Pharma (Group)
	Organisation 2	Nasdaq Global Market
	Group	Nasdaq OMX (Group)
	Product	respiratory drug
	Product 2	investment banking
	Index term	Verona Pharma–SEVERAL: investment, 201704 US IPO $78m with 5.768m ADSs at $13.5/ADS at Nasdaq Global Market
	Person	Ebsworth, David (Galenica 200910–201508 CEO Vifor Pharma RETIRES 8/14 before OGS CEO + Bayer Head Pharma

Record changed: 2023-06-05

Advertisement

More documents for Verona Pharma (Group)

• [1] Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London....
• [2] Renaissance Capital. (4/26/17). "News: Verona Pharma Prices IPO at $13.50"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.